Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05993832 · ClinicalTrials.gov registry record · NA

Word Learning in Deaf Children Using Eye-tracking and Behavioral Measures

A NA study of Deafness, sponsored by Boston University Charles River Campus.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT05993832: Recruiting NA study of Deafness, sponsored by Boston University Charles River Campus.

NCT05993832 is a NA study of Deafness that is actively recruiting participants, run by Boston University Charles River Campus. The registered enrollment target is 40 participants, below the 614-participant average among 11 other Deafness trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05993832, a NA study of Deafness, is actively recruiting participants, sponsored by Boston University Charles River Campus.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

Mutual exclusivity is a word learning constraint in which the learner assumes that a given word refers to only one category of objects. In spoken languages, mutual exclusivity has been demonstrated in monolingual children as young as 17 months and cross-linguistically, while multilingual learners show an attenuated mutual exclusivity bias. Mutual exclusivity has not been robustly demonstrated in deaf children acquiring American Sign Language (ASL). Further, it is unclear if mutual exclusivity applies to those learning both a signed and a spoken language. Like unimodal bilinguals, bimodal bilingual (BiBi) children learn two words for an object, but these words are separated by modality. A BiBi child could therefore assume that all objects have two words (like unimodal bilinguals) or that all objects have one spoken word and one sign (within-modality mutual exclusivity). The goals of the current study are to demonstrate mutual exclusivity in monolingual deaf children acquiring ASL, and to determine if BiBi deaf children utilize mutual exclusivity within each modality.

Primary Outcome

Children will select one of the two objects on the table in front of them. Their selection will be scored as correct or incorrect based on the target object.

Conditions Studied

Interventions

  • OTHER input cue

Study Locations (1)

Massachusetts

  • Boston University - Boston

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2023-08-07
Est. Completion 2027-01
Phase NA

What NCT05993832 shows while recruiting

NCT05993832 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 614-participant average among 11 other Deafness trials with a reported enrollment target (93% lower).

The record links to 1 condition, with Deafness appearing as the primary indexed condition, and to 1 intervention - of which input cue is the first listed.

NCT05993832 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05993832 about?

NCT05993832 is a clinical study titled "Word Learning in Deaf Children Using Eye-tracking and Behavioral Measures". Mutual exclusivity is a word learning constraint in which the learner assumes that a given word refers to only one category of objects. In spoken languages, mutual exclusivity has been demonstrated in monolingual children as young as 17 months and cross-linguistically, while multilingual learners sh...

What is the current status of trial NCT05993832?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2023-08-07. Estimated completion is 2027-01.

What conditions does trial NCT05993832 study?

This clinical trial studies the following conditions: Deafness.

What interventions are being tested in trial NCT05993832?

The interventions under investigation include: input cue (OTHER).

Who is sponsoring clinical trial NCT05993832?

This trial is sponsored by Boston University Charles River Campus, which has 104 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05993832 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Deafness

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05993832's enrollment target sits among peer trials

40 9th of 11 higher than 2 of 11 other Deafness trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Deafness trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05993832, the US trial registry maintained by the National Library of Medicine. NCT05993832 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.